SGN-CD33A (Vadastuximab Talirine) followed by Allogeneic Hematopoietic Stem Cell Transplant (AlloHSCT) Results in Durable Complete Remissions (CRs) in Patients with Acute Myeloid Leukemia (AML)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Stein, AS; Walter, RB; Advani, AS; Ho, PA; Erba, HP

Published Date

  • March 2016

Published In

Volume / Issue

  • 22 / 3

Start / End Page

  • S211 - S212

Published By

International Standard Serial Number (ISSN)

  • 1083-8791

Digital Object Identifier (DOI)

  • 10.1016/j.bbmt.2015.11.608